Pricing
  1. US-listed companies
  2. Tonix Pharmaceuticals Holding Corp.
  3. Financials
  4. Cash from investing

Tonix Pharmaceuticals Holding Corp. (TNXP)

Market cap
$122.55M
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-0-99.59%
Dec 31, 2023-29-39.62%
Dec 31, 2022-48+36.37%
Dec 31, 2021-35+312.27%
Dec 31, 2020-9+50276.47%
Dec 31, 2019-0-100.24%
Dec 31, 20177-56.80%
Dec 31, 201617-168.65%
Dec 31, 2015-24+6066.07%
Dec 31, 2014-0+2513.33%
Dec 31, 2013-0-58.06%
Dec 31, 2012-0-11942.05%
Dec 31, 20110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat